News
Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has ...
5d
NDTV Profit on MSNCipla To Take On Eli Lilly, Novo Nordisk With Entry Into India's Weigh-Loss Drug SectorCipla is preparing to enter the weight-loss drug making sector, heating the competition with US-based Eli Lilly & Co and Danish firm Novo Nordisk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results